Basilea Pharmaceutica AG BPMUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 66.08M | 57.97M | 48.94M | 66.01M | 83.61M |
| Total Depreciation and Amortization | 4.83M | 4.78M | 4.69M | 4.50M | 4.34M |
| Total Amortization of Deferred Charges | 399.30K | 498.30K | 578.10K | 575.70K | 574.60K |
| Total Other Non-Cash Items | 11.35M | 11.06M | 10.41M | 7.02M | 3.61M |
| Change in Net Operating Assets | -9.72M | 591.80K | 11.02M | 5.22M | -570.30K |
| Cash from Operations | 72.94M | 74.91M | 75.63M | 83.33M | 91.56M |
| Capital Expenditure | -3.40M | -3.33M | -3.25M | -2.52M | -1.80M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 0.00 | 0.00 |
| Other Investing Activities | -232.20K | -265.80K | -294.50K | -217.70K | -141.40K |
| Cash from Investing | -3.63M | -3.60M | -3.54M | -2.74M | -1.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 570.00K | 631.00K | 692.00K | 673.00K | 654.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.40M | -17.26M | -22.12M | -18.63M | -15.15M |
| Cash from Financing | -14.89M | -20.58M | -25.52M | -21.18M | -16.84M |
| Foreign Exchange rate Adjustments | -32.80K | -32.50K | -31.60K | -55.80K | -80.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.38M | 50.70M | 46.53M | 59.36M | 72.70M |